CTKB EV/EBITDA
-959.22
-103.21-12.06%
Tue, 21 Jan 2025 23:34:56 GMT
Summary:
As of January 22, 2025, CTKB EV/EBITDA is -959.22, with a fall of -103.21 (-12.06%) during the most recent trading day. Over the past year, it has dropped by -748.73 (-355.71%). CTKB EV/EBITDA is now -312.96% below its all-time high of 450.42.CTKB EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTKB EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -12.1% |
| 1 m1 month | +6.6% |
| 3 m3 months | -19.9% |
| 6 m6 months | -609.0% |
| ytdytd | +9.6% |
| 1 y1 year | -355.7% |
| 5 y5 years | - |
CTKB EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -856.01 | -12.1% | -1219 | +21.3% |
| 3 m | 3-month | -710.09 | -35.1% | -1249 | +23.2% |
| 6 m | 6-month | -96.65 | -892.5% | -1249 | +23.2% |
| 1 y | 1-year | -96.65 | -892.5% | -1249 | +23.2% |
| 3 y | 3-year | 450.42 | -313.0% | -3172 | +69.8% |
| 5 y | 5-year | 450.42 | -313.0% | -3172 | +69.8% |
| alltime | all time | 450.42 | -313.0% | -3172 | +69.8% |
Cytek Biosciences EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -959.22(-9.5%) |
| 2024 | -1060.44(+349.9%) |
| Date | Value |
|---|---|
| 2023 | -235.70(-302.7%) |
| 2022 | 116.26(-43.0%) |
| 2021 | 203.81 |
FAQ
- What is Cytek Biosciences EV/EBITDA?
- What is the all time high EV/EBITDA for Cytek Biosciences?
- What is CTKB EV/EBITDA year-to-date change?
- What is Cytek Biosciences EV/EBITDA year-on-year change?
What is Cytek Biosciences EV/EBITDA?
The current EV/EBITDA of CTKB is -959.22
What is the all time high EV/EBITDA for Cytek Biosciences?
Cytek Biosciences all-time high EV/EBITDA is 450.42
What is CTKB EV/EBITDA year-to-date change?
Cytek Biosciences EV/EBITDA has changed by +101.22 (+9.55%) since the beginning of the year
What is Cytek Biosciences EV/EBITDA year-on-year change?
Over the past year, CTKB EV/EBITDA has changed by -748.73 (-355.71%)